Gf Fund Management Co. Ltd. Roivant Sciences Ltd. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 18,641 shares of ROIV stock, worth $213,439. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,641
Previous 15,285
21.96%
Holding current value
$213,439
Previous $181 Million
4.02%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$753 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$708 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$527 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$467 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$411 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.07B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...